Analyst firms · B. Riley Securities · BCYC

B. Riley Securities BCYC price target and rating history

Bicycle Therapeutics plc (BCYC) · Health Care

B. Riley Securities rates Bicycle Therapeutics plc (BCYC) Neutral with a $28 price target, as of its latest action on Aug 7, 2024. It has published 4 rating actions on BCYC since September 2021, including 1 upgrade and 2 downgrades.

Current rating
Neutral
Price target
$28
Median target, all firms
Too few
Actions on BCYC
4

B. Riley Securities price target on BCYC

$56$42$2820222023202420252026
B. Riley Securities price target on BCYC, each point a stated target, September 2021 to August 2024.

Every B. Riley Securities rating on BCYC

Questions about B. Riley Securities and BCYC

What is B. Riley Securities's price target for BCYC?
B. Riley Securities's latest stated price target for Bicycle Therapeutics plc (BCYC) is $28, from its action on Aug 7, 2024.
What is B. Riley Securities's rating on BCYC?
B. Riley Securities rates BCYC Neutral, a neutral rating, as of Aug 7, 2024.
When did B. Riley Securities last change its view on BCYC?
On Aug 7, 2024, B. Riley Securities downgrades to Neutral from Buy, price target $33 to $28.

More BCYC rating histories

All B. Riley Securities ratingsBCYC news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.